论文部分内容阅读
以研究开发为主的生产专利产品的跨国农药公司之间的兼并组合为生产非专利产品的农药公司提供了机遇和挑战,受美国和欧洲反托拉斯法的制约,大公司兼并过程中会将某些产品剥离出来,那些专利已过期的产品通常被非专利产品生产公司购买。自1996年以来,世界非专利产品生产公司得到稳步发展,但非专利产品生产公司也面临着政府要求老产品重新注册和产品市场供过于求的挑战。目前两大类农药公司的区分界限变得越来越模糊,今后非专利产品生产公司的最好选择是合并成较大的公司或同世界大公司合作。
The combination of research and development-based multinational pesticide companies that produce patented products offers opportunities and challenges for pesticide companies that produce generic products. Due to the antitrust laws of the United States and Europe, the merger of large companies Some of these products are spun off, and those whose patents have expired are usually purchased by non-patent production companies. Since 1996, the world’s generic product manufacturing companies have been steadily growing, but the non-patent product manufacturing companies are also facing the government’s challenge of re-registering old products and oversupply in the product market. At present, the distinction between the two major types of pesticide companies has become more and more blurred. In the future, the best option for non-patent product manufacturing companies is to merge into larger companies or cooperate with major world companies.